15:57 Jan 17
Caplin Point Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Caplin Point Laboratories Ltd.
Industry Pharmaceuticals
15:57 Jan 17
Quality
50/100
Medium Financial Strength
Valuation
28/100
Expensive Valuation
Technical
55/100
Technically Neutral
Strength
7
Weakness
5
Opportunity
1
Threats
0
16.77K
Market Cap (Cr)
33.98
PE Ratio
6.60
Price to Book Ratio
39.06
RSI
26.98 %
Net Profit Margin
Download Our App On:
